A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures - Trial 2016-004954-13
Access comprehensive clinical trial information for 2016-004954-13 through Pure Global AI's free database. This phase not specified trial is sponsored by Eisai Taiwan Inc. and is currently status unknown. The study focuses on Epilepsy.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2016-004954-13
Trial Details
EU Clinical Trials Register • 2016-004954-13
A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures
Study Focus
Sponsor & Location
Eisai Taiwan Inc.
Eisai Inc.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Percentage Change of Monthly Seizure Frequency at the End of the 16-week Treatment From Baseline
ICD-10 Classifications
Epilepsy
Epilepsy, unspecified
Other epilepsy
Status epilepticus
Other status epilepticus
Data Source
EU Clinical Trials Register
2016-004954-13
Non-Device Trial